An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea: response to mikhail and cope

Anthony H. Barnett, Manfred Dreyer, Peter Lange, Marjana Serdarevic-Pehar, Exubera Phase III Study Group

    Fingerprint

    Dive into the research topics of 'An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea: response to mikhail and cope'. Together they form a unique fingerprint.

    Medicine & Life Sciences